Eton Pharmaceuticals (ETON) Capital Expenditures (2018 - 2025)
Eton Pharmaceuticals (ETON) posted Capital Expenditures of $49000.0 for Q4 2025, down 82.75% sequentially from $284000.0 in Q3 2025, and up 308.33% YoY from $12000.0 in Q4 2024.
Eton Pharmaceuticals (ETON) Capital Expenditures (2018 - 2025) Analysis & Trends
Eton Pharmaceuticals has reported Capital Expenditures for 7 years, with the latest figure at $49000.0 in Q4 2025.
- Quarterly Capital Expenditures rose 308.33% year-over-year to $49000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $333000.0 (up 1180.77% YoY) and the FY2025 annual result came in at $333000.0, up 1180.77% from the prior year.
- Capital Expenditures declined to $49000.0 in Q4 2025 per ETON's latest filing, from $284000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $284000.0 in Q3 2025 and troughed at $2000.0 in Q3 2021.
- A 4-year average of $44777.8 and a median of $12000.0 in 2022 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2021 and 2025: Capital Expenditures tumbled 90.91% in 2021, then soared 308.33% in 2025.
- Over 4 years, Capital Expenditures stood at $4000.0 in 2021, then surged by 200.0% to $12000.0 in 2022, then changed by 0.0% to $12000.0 in 2024, then soared by 308.33% to $49000.0 in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered $49000.0, $284000.0, and $12000.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.67 Bn | 1.64 Bn | 25.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49,000.00 |
| Dec 31, 2025 | 49,000.00 |
| Sep 30, 2025 | 284,000.00 |
| Sep 30, 2025 | 284,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Jun 30, 2022 | 11,000.00 |
| Jun 30, 2022 | 11,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Dec 31, 2020 | 44,000.00 |
| Dec 31, 2020 | 44,000.00 |